GT
TARO

Glenmede Trust’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Glenmede Trust’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-72
Closed -$3K – 2355
2020
Q3 		$3K Hold
72
– – ﹤0.01% 2220
2020
Q2 		$4K Buy
72
+48
+200% +$3.22K ﹤0.01% 2149
2020
Q1 		$2K Hold
24
– – ﹤0.01% 2884
2019
Q4 		$2K Hold
24
– – ﹤0.01% 2884
2019
Q3 		$1 Hold
24
– – ﹤0.01% 2957
2019
Q2 		$2 Hold
24
– – ﹤0.01% 2889
2019
Q1 		$2 Hold
24
– – ﹤0.01% 2864
2018
Q4 		$2 Buy
+24
New +$2.31K ﹤0.01% 2805
2016
Q4 		– Sell
-11
Closed -$1K – 2641
2016
Q3 		$1K Sell
11
-9
-45% -$1.19K ﹤0.01% 2513
2016
Q2 		$2K Buy
+20
New +$2.84K ﹤0.01% 2416

Other funds holding TARO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Glenmede Trust's TARO Position: Q4 2020 in Review

Glenmede Trust sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2020, closing a stake of 72 shares — an estimated $3K sold.

Glenmede Trust first reported a position in TARO in Q2 2016 and held it in 10 quarters. The position peaked at $4K in Q2 2020. 84 funds tracked by Wall St. Rank hold TARO as of Q4 2020.

  • Glenmede Trust reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2020 after selling out during the quarter.
  • Glenmede Trust sold 72 Taro Pharmaceutical Industries Ltd. shares in Q4 2020, an estimated $3K.
  • Glenmede Trust first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2016 and held it in 10 quarters.
  • Glenmede Trust's Taro Pharmaceutical Industries Ltd. position peaked at $4K in Q2 2020.
  • 84 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.